Zydus Lifesciences Ltd.

ZYDUSLIFE

₹1206.05

0.02% (0.25)

Market Cap

₹1,21,377 Cr.

P/E

31.45

About

Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), a Company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with busine… Read more

Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), a Company limited by… Read more

Low

568

52W Range

High

1215

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

19.46%

3yr Average

19.02%

5yr Average

16.96%

Net Profit Margin

Latest

19.74%

3yr Average

20.27%

5yr Average

16.78%

ROCE

Latest

22.0%

3yr Average

18.21%

5yr Average

17.68%

Debt to Equity

Latest

0.04

3yr Average

0.12

5yr Average

0.3

Market Share

1.08 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

3.46 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

18.14 %

(as of Nov 21)

Historic

Anti-Malarial - Market Share

0.34 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

95.90 %

(as of Mar 24)

Source/Historic

Artificial Sweetener Market Share (Sugar Free Natura)

0.16 %

(as of Nov 21)

Historic

Blood Related - Market Share

4.73 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

4.30 %

(as of Mar 24)

Source/Historic

Complan

3.51 %

(as of Nov 21)

Historic

Dermatology - Market Share

9.08 %

(as of Nov 21)

Historic

Endocrinology - Market Share

45.60 %

(as of Mar 24)

Source/Historic

Face Wash Market Share

3.54 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

59.50 %

(as of Mar 24)

Source/Historic

Glucon-D

3.89 %

(as of Nov 21)

Historic

Gynecology - Market Share

0.63 %

(as of Nov 21)

Historic

Neurological - Market Share

0.11 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

5.91 %

(as of Nov 21)

Historic

Pain - Market Share

2.90 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

35 %

(as of Mar 24)

Source/Historic

Powder Market Share(Nycil)

5.57 %

(as of Nov 21)

Historic

Respiratory - Market Share

5.37 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

1.58 %

(as of May 19)

Historic

Stomatological - Market Share

0.06 %

(as of Nov 21)

Historic

Urology - Market Share

0 %

(as of Jun 22)

Historic

Vaccines - Market Share

1.40 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up - India Formulations

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

US DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

EverYuth

Nutralite

SugarFree

Suppliers

Time Technoplast Ltd.
EPL Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
Vidhi Specialty Food Ingredients Ltd.
Gulshan Polyols Ltd.

FAQs on Zydus Lifesciences Ltd. Business

What does Zydus Lifesciences do?

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an integrated pharmaceutical company based in India. They cover the entire value chain from research to distribution, specializing in API and human formulations.

Who are the competitors of Zydus Lifesciences?

Zydus Lifesciences major competitors are Cipla, Dr. Reddy's Lab, Torrent Pharma, Mankind Pharma, Lupin, Aurobindo Pharma, Alkem Laboratories.
Market Cap of Zydus Lifesciences is ₹1,21,377 Crs.
While the median market cap of its peers are ₹83,886 Crs.

Is Zydus Lifesciences financially stable compared to its peers?

Zydus Lifesciences seems to be less financially stable compared to its peers.
Altman Z score of Zydus Lifesciences is 11.8 and is ranked 4 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun			Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec